Lihuan Zhu
No. 134 East Street
Fuzhou, 350001, China
Fuzhou, 350001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Toxicological impact of benzo[a]pyrene on esophageal cancer: an integrated analysis via network toxicology, machine learning, and molecular docking.
Journal: Frontiers in immunology
Published: May 14, 2026
Value of the 14-gene molecular assay in efficacy assessment of neoadjuvant chemoimmunotherapy for non-small cell lung cancer.
Journal: Frontiers in molecular biosciences
Published: April 27, 2025
Favorable outcomes with jejunal interposition without vascular anastomosis for esophagectomy in cancer patients: a single-center experience.
Journal: BMC surgery
Published: March 06, 2025
Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial.
Journal: BMC medicine
Published: December 31, 2024
Predictive value of crossover sign for outcome of ultrasound-guided vacuum aspiration in women with Cesarean scar pregnancy.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: February 19, 2023
miR-452-5p suppressed the metastasis of Non-small cell lung cancer through regulating Moesin.
Journal: Journal of Cancer
Published: February 04, 2023
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway.
Journal: BioMed research international
Published: December 17, 2022
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: December 13, 2022
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study.
Journal: Journal of gastrointestinal oncology
Published: November 11, 2022
USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
Journal: BioMed research international
Published: July 30, 2022
CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis.
Journal: Bioengineered
Published: February 14, 2022
TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1.
Journal: Cancer biology & therapy
Published: January 03, 2022
Last Updated: 09/26/2026